Aurora Innovation plans to scale its autonomous trucking fleet to 200 vehicles by year-end 2026 following the launch of Aurora Driver 2. Aurora Innovation (AUR) announced plans to deploy 200 driverless trucks by the end of 2026, marking a significant expansion of its auton
Defense contractor L3Harris raises full-year earnings guidance after reporting $7.3 billion in Q2 orders and a $42 billion backlog. L3Harris Technologies raised its 2026 earnings per share forecast to a range of $11.80-$12.00, up from prior guidance. The company cited stro
Meta’s Q2 revenue rose 28% to $60.8 billion, but adjusted EPS fell short at $6.18 due to one-time charges. Meta Platforms reported second-quarter revenue of $60.8 billion, up 28% year over year and $2 billion above analyst estimates. However, adjusted earnings per share de
Starbucks revenue totals $9.32 billion, topping estimates Starbucks reported strong quarterly results, with revenue of $9.32 billion exceeding the $9.16 billion consensus estimate. The company's adjusted earnings per share came in at 85 cents, beating the 66-cent c
The RFID solutions provider reports record Q2 2026 revenue and endpoint IC bookings, signaling accelerating demand. Impinj projected third-quarter revenue of $105.5M to $108.5M, reflecting continued momentum in endpoint integrated circuit demand. The company cited record Q
PMT outlines aggressive securitization strategy following agreement to offload $13B in Agency mortgage servicing rights. PennyMac Mortgage Investment Trust (PMT) announced plans to execute approximately 30 securitizations in 2026. The move follows an agreement to sell $13
MGP Ingredients reports Q2 2026 sales of $124.4 million and adjusted EBITDA of $27.6 million amid margin guidance. MGP Ingredients maintained its 2026 adjusted EBITDA outlook of $90M-$98M during its Q2 2026 earnings call. The company reported second-quarter sales of $124.4
Microsoft’s $90 billion Q4 revenue and 43% Azure growth beat estimates, easing AI spending concerns and lifting shares. Microsoft reported fiscal fourth-quarter revenue of $90 billion, up 18% year-over-year and above the $87.6 billion consensus estimate. Adjusted earnings
Integra LifeSciences reaffirms full-year earnings guidance and projects third-quarter revenue between $410M and $425M. Integra LifeSciences maintained its adjusted earnings per share forecast for Q2 2026 at $2.40 to $2.50. The company also guided third-quarter revenue to a
Corcept Therapeutics reports Q2 2026 revenue of $256.1 million, up 32% year-over-year, driven by strong sales of Korlym and Lifyorli. Corcept Therapeutics posted Q2 2026 revenue of $256.1 million, a 32% increase from the same period last year. The growth was fueled by $208
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.